113 results
Page 2 of 6
S-1/A
x1rcb
10 Mar 22
IPO registration (amended)
9:16am
S-1/A
EX-1.1
32cp xx6t
10 Mar 22
IPO registration (amended)
9:16am
S-1/A
EX-14
xj6mkumcnnmb
10 Mar 22
IPO registration (amended)
9:16am
8-K
p9pz1ts 82j9
9 Mar 22
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
EX-10.1
lown tcjt8h
4 Mar 22
Departure of Directors or Certain Officers
8:00am
S-1
izdrn5dv 2v
17 Dec 21
IPO registration
4:31pm
8-K
EX-10.4
nss56a4ss
10 Dec 21
Entry into a Material Definitive Agreement
4:53pm
8-K
EX-10.2
pv2s6y m9i
10 Dec 21
Entry into a Material Definitive Agreement
4:53pm
8-K
EX-10.3
6kck5h0dml587vh5bpi
10 Dec 21
Entry into a Material Definitive Agreement
4:53pm
8-K
lmd wl48e
10 Dec 21
Entry into a Material Definitive Agreement
4:53pm
8-K
kk6s7
18 Feb 21
QSAM Biosciences Appoints Charles J. Link, Jr., M.D., Experienced Biotech Executive and Innovator, to Board of Directors
4:00pm
8-K
EX-99.1
1rszm6
12 Feb 21
Other Events
12:00am
8-K
EX-10.1
dsi5sl
28 Jan 21
QSAM Biosciences Closes Series B Preferred Private Placement; $2.5 Million in New Capital to Fund Upcoming Clinical Trials
4:15pm
8-K
ah8v1lh
31 Dec 20
Departure of Directors or Certain Officers
4:00pm